Antimicrobial Susceptibility and Multiplex PCR Screening of AmpC Genes From Isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 3, 2010, Pages 180-187

  Kao, Chih Chauan ^a   Liu, Meei Fang ^a   Lin, Chin Fu ^a   Huang, Yi Ching ^a   Liu, Po Yu ^a   Chang, Ching Wen ^a   Shi, Zhi Yuan ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

AmpC; Citrobacter; Enterobacter; extended spectrum lactamases; Serratia

Indexed keywords

BETA LACTAMASE AMPC; CEFTAZIDIME; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; FLOMOXEF; IMIPENEM; MOXIFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CITROBACTER FREUNDII; COLONY FORMING UNIT; CONTROLLED STUDY; DISK DIFFUSION; DRUG DETERMINATION; ENTEROBACTER CLOACAE; GENE IDENTIFICATION; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; SCREENING TEST; SERRATIA MARCESCENS; TAIWAN;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CITROBACTER FREUNDII; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER CLOACAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SERRATIA MARCESCENS;

EID: 77953085418     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60029-1     Document Type: Article

References (27)

1. Yu W.L., Chuang Y.C., and Walther-Rasmussen J. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 39 (2006) 264-277
2. Karlowsky J.A., Jones M.E., Thornsberry C., Friedland I.R., and Sahm D.F. Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001. Antimicrob Agents Chemother 47 (2003) 1672-1680
3. Choi S.H., Lee J.E., Park S.J., Choi S.H., Lee S.O., Jeong J.Y., et al. Emergence of Antibiotic Resistance during Therapy for Infections Caused by Enterobacteriaceae Producing AmpC β-Lactamase: Implications for Antibiotic Use. Antimicrob Agents Chemother 52 (2008) 995-1000
4. Odeh R., Kelkar S., Hujer A.M., Bonomo R.A., Schreckenberger P.C., and Quinn J.P. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli. Clin Infect Dis 35 (2002) 140-145
5. Philippon A., Arlet G., and Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 46 (2002) 1-11
6. th Informational Supplement. M100-S16
7. Yu W.L., Cheng K.C., Chi C.J., Chen H.E., Chuang Y.C., and Wu L.T. Characterization and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan. Clin Microbiol Infect 12 (2006) 579-582
8. Hanson N.D. AmpC beta-lactamases: what do we need to know for the future?. J Antimicrob Chemother 52 (2003) 2-4
9. Jacoby G.A., Walsh K.E., and Walker V.J. Identification of Extended-Spectrum, AmpC, and Carbapenem-Hydrolyzing β-Lactamases in Escherichia coli and Klebsiella pneumoniae by Disk Tests. J Clin Microbiol 44 (2006) 1971-1976
10. Thomson K.S. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis 7 (2001) 333-336
11. Pérez-Pérez F.J., and Hanson N.D. Detection of Plasmid-Mediated AmpC beta-Lactamase Genes in Clinical Isolates by Using Multiplex PCR. J Clin Microbiol 40 (2002) 2153-2162
12. Yu W.L., Wu L.T., Pfaller M.A., Winokur P.L., and Jones R.N. Confirmation of extended-spectrum beta-lactamase-producing Serratia marces-cens: preliminary report from Taiwan. Diagn Microbiol Infect Dis 45 (2003) 221-224
13. Wu T.L., Chia J.H., Su L.H., Kuo A.J., Chu C., and Chiu C.H. Dissemination of extended-spectrum beta-lactamase-producing Enterobacte-riaceae in pediatric intensive care units. J Clin Microbiol 41 (2003) 4836-4838
14. Hung P.P., Lin Y.H., Lin C.F., Liu M.F., and Shi Z.Y. Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality. J Microbiol Immunol Infect 41 (2008) 137-144
15. Deshpande L.M., Jones R.N., Fritsche T.R., and Sader H.S. Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004). Int J Antimicrob Agents 28 (2006) 578-581
16. Pitcher D.G., Saunders N.A., and Owen R.J. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol 8 (1989) 151-156
17. bla CTX-M genes in Enterobacteriaceae. APMIS 115 (2007) 1400-1408
18. Cheng K.C., Chuang Y.C., Wu L.T., Huang G.C., and Yu W.L. Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan. Jpn J Infect Dis 59 (2006) 147-152
19. Yu W.L., Winokur P.L., Von Stein D.L., Pfaller M.A., Wang J.H., and Jones R.N. First description of Klebsiella pneumoniae Harboring CTX-M β-Lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrob Agents Chemother 46 (2002) 1098-1100
20. Malik A., Celik E.K., Bohn C., Böckelmann U., Knobel K., and Grohmann E. Detection of conjugative plasmids and antibiotic resistance genes in anthropogenic soils from Germany and India. FEMS Microbiol Lett 279 (2008) 207-216
21. Tan T.Y., and Ng L.S. Comparison of three standardized disc susceptibility testing methods for colistin. J Antimicrob Chemother 58 (2006) 864-867
22. Gönüllü N., Aktas Z., Salcioglu M., Bal C., and Ang O. Comparative in vitro activities of five quinolone antibiotics, including gemifloxacin, against clinical isolates. Clin Microbiol Infect 7 (2001) 499-503
23. Ma L., Chang F.Y., Fung C.P., Chen T.L., Lin J.C., Lu P.L., et al. Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Microb Drug Resist 11 (2005) 31-39
24. Bell J.M., Chitsaz M., Turnidge J.D., Barton M., Walters L.J., and Jones R.N. Prevalence and Significance of a Negative Extended-Spectrum β-Lactamase (ESBL) Confirmation Test Result after a Positive ESBL Screening Test Result for Isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program. J Clin Microbiol 45 (2007) 1478-1482
25. Goossens H., and Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase-and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and United States (1997-2004). Diagn Microbiol Infect Dis 53 (2005) 257-264
26. Yan J.J., Ko W.C., Wu H.M., Tsai S.H., Shuang C.L., and Wu J.J. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J Clin Microbiol 42 (2004) 5337-5340
27. Yan J.J., Hsueh P.R., Lu J.J., Chang F.Y., Shvr J.M., Wan J.H., et al. Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob Agents Chemother 50 (2006) 1861-1864